[1] NAHMIAS A, JOSEY W E, NAIB Z M, et al. Perinatal risk associated with maternal genital herpes simplex virus infection[J]. Am J Obstet Gynecol, 1971, 110(6): 825-837. [2] BARTOVA E, SEDLAK K. Toxoplasma gondii and Neospora caninum antibodies in goats in the Czech Republic[J]. Veterinarni Medicina, 2018, 57(3): 111-114. [3] ORENSTEIN W A, HINMAN A, NKOWANE B, et al. Measles and Rubella Global Strategic Plan 2012—2020 midterm review[J]. Vaccine, 2018,36(Suppl 1): A1-A34. [4] AGHOLI M, SAFAEI A, RAMZI M, et al. A survey of the frequency of cytomegalovirus-associated diarrhea in immunocompromised patients using a non-invasive method[J]. Iran J Microbiol, 2018, 10(2):143-150. [5] WEILAND M. A neuropsychological analysis of herpes simplex virus-1 (HSV-1) infection and HSV-1 encephalitis: biological mechanisms, clinical presentations, and brain-body-behavior manifestations [J]. Act Nerv Super, 2018, 60(2): 40-47. [6] CHUNG M H, SHIN C O, LEE J. TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates efficacy study in a single institute in Korea[J]. Korean J Pediatr, 2018, 61(4):114-120. [7] 刘震忠, 吴凤琪, 闫静, 等. 2015~2016年天津地区新生儿TORCH血清学筛查及感染特点[J]. 现代检验医学杂志, 2017, 32(4):133-136. [8] 杨琰琰, 刘功振. 新生儿及婴儿TORCH感染血清学检测分析[J]. 国际检验医学杂志, 2019, 40(8):901-904. [9] 杨琼芬, 张惠, 熊萍, 等. 遵义市孕妇TORCH感染血清流行病学监测[J]. 中华流行病学杂志, 2003,24(9):853-853. [10] HILDITCH C, KEIR A K. Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection[J]. Acta Paediatr, 2018, 107(5): 906. [11] 张宁, 李奇玉, 李文, 等. 孕前TORCH筛查专家共识[J]. 发育医学电子杂志, 2019, 7(2):81-85. [12] 朱宇宁, 陈雁. 血清学产前筛查的现状与未来展望[J]. 中华检验医学杂志, 2019, 42(7):493-497. [13] HUI L, BIANCHI D W. Noninvasive prenatal DNA testing: the vanguard of genomic medicine[J]. Annu Rev Med, 2017, 68(1): 459-472. [14] 李媛媛, 杨海霞, 沈晓亚. 产前超声检查在妊娠期病原体感染胎儿中的诊断价值[J]. 西部医学, 2018,30(1):124-127. [15] GU X, HAN L, CHEN J, et al. Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing [J]. Medicine (Baltimore), 2018, 97(15):e0112. [16] GUDOWSKA M, GRUSZEWSKA E, PANASIUK A, et al. Selected noninvasive markers in diagnosing liver diseases[J]. Lab Med, 2016, 47(1): 67-72. |